Prostate Cancer Clinical Trial

Clinical Trial Finder Prostate Cancer Trials

Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)

See Locations Near You

Summary

This is an open label, Phase 2 trial of APC8015F immunotherapy in men with objective disease progression on protocol D9902 part B (NCT00065442)

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Objective disease progression
Subjects must have been enrolled in the APC-Placebo arm of D9902B (NCT00065442)

Exclusion Criteria:

Infection requiring IV antibiotics
Treatment with anticancer interventions within 14 days prior to enrollment
Any medical condition which could compromise the study's objectives (discretion from sponsor)

Study is for people with:

Prostate Cancer

Phase:

Phase 2

Estimated Enrollment:

113

Study ID:

NCT00849290

Recruitment Status:

Completed

Sponsor:

Dendreon

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

UCLA
Los Angeles California, , United States
USC Keck School of Medicine
Los Angeles California, , United States
Sutter Cancer Center
Sacramento California, , United States
Kaiser Permanente Medical Group
San Diego California, , United States
Sharp HealthCare
San Diego California, , United States
UCSF Cancer Center
San Francisco California, , United States
Helen F. Graham Cancer Center
Newark Delaware, , United States
Lombardi Cancer Center
Washington District of Columbia, , United States
Walter Reid Army Medical Center
Washington District of Columbia, , United States
Miami Cancer Center
Miami Florida, , United States
Hematology/Oncology Associates of the Treasure Coast
Port Saint Lucie Florida, , United States
Georgia Urology, P.A.
Atlanta Georgia, , United States
Midwest Prostate & Urology Health Center
Chicago Illinois, , United States
Loyola University
Maywood Illinois, , United States
Lutheran General Cancer Center
Park Ridge Illinois, , United States
Indiana University
Indianapolis Indiana, , United States
Myron I Murdock MD LLC
Greenbelt Maryland, , United States
Dana-Farber Cancer Institute
Boston Massachusetts, , United States
Lahey Clinic (Department of Urology)
Burlington Massachusetts, , United States
University of Minnesota
Minneapolis Minnesota, , United States
Mayo Clinic
Rochester Minnesota, , United States
Nevada Cancer Institute
Las Vegas Nevada, , United States
Hackensack University Medical Center
Hackensack New Jersey, , United States
Associates in Urology, LLC
West Orange New Jersey, , United States
Albany Regional Cancer Center
Albany New York, , United States
The Urological Institute of Northeastern New York
Albany New York, , United States
North Shore Hematology Oncology Associates
East Setauket New York, , United States
New York Medical College
Hawthorne New York, , United States
Beth Israel Cancer Center
New York New York, , United States
Clinical Cancer Center
New York New York, , United States
Mount Sinai School of Medicine
New York New York, , United States
New York University
New York New York, , United States
Staten Island Urological Research
Staten Island New York, , United States
McKay Urology
Charlotte North Carolina, , United States
Duke University Medical Center
Durham North Carolina, , United States
University of Cincinnati
Cincinnati Ohio, , United States
Cleveland Clinic Foundation
Cleveland Ohio, , United States
EACRI
Portland Oregon, , United States
Kaiser Permanente Medical Group
Portland Oregon, , United States
Center for Urologic Care
Bryn Mawr Pennsylvania, , United States
Jefferson Medical College
Philadelphia Pennsylvania, , United States
Grand Strand Urology
Myrtle Beach South Carolina, , United States
Mary Crowley
Dallas Texas, , United States
Baylor College of Medicine
Houston Texas, , United States
University of Utah
Salt Lake City Utah, , United States
Urology of Virginia, PC
Norfolk Virginia, , United States
Seattle Cancer Care Alliance
Seattle Washington, , United States
Virginia Mason Medical Center
Seattle Washington, , United States
Cancer Care Northwest
Spokane Washington, , United States
Wenatchee Valley Medical Center
Wenatchee Washington, , United States
University of Wisconsin, Madison
Madison Wisconsin, , United States
University of Wisconsin
Madison Wisconsin, , United States
St. Luke's Hospital Immunotherapy Program
Milwaukee Wisconsin, , United States
Can-Med Medical Research, Inc.
Victoria British Columbia, , Canada
London Health Sciences Centre
London Ontario, , Canada
Princess Margaret Hospital
Toronto Ontario, , Canada
Sunnybrook & Women's College HSC
Toronto Ontario, , Canada
Hospital Notre Dame du CHUM
Montreal Quebec, , Canada

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Phase:

Phase 2

Estimated Enrollment:

113

Study ID:

NCT00849290

Recruitment Status:

Completed

Sponsor:


Dendreon

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider